把三张表、经营指标、SEC / 巨潮 / 港交所原始财报、业绩材料和电话会放到同一条可核验时间线上。 披露事实、结构化补位值与派生指标分开标注，缺失逐字稿不会用摘要或模型生成内容补齐。
单季、累计、年度和资产负债表时点分开保存；每个数值都保留单位、申报日、表单、XBRL 概念或原始中文字段。
美股链接 SEC 法定申报和发行人 IR，A 股链接巨潮原始 PDF，港股链接港交所披露易原始年报与中报。分部、订单、产能和客户集中度只在有可核验披露时展示。
官方电话会入口与已授权逐字稿分开。没有合法取得的全文时只显示材料可用性，不生成或拼接虚假的逐字稿。
三张表会执行资产负债、毛利润、税前利润等勾稽检查；超出容差的记录保留原值并标记警告， 不会为了让公式“对上”而修改公司披露。
| 2026-04-30 |
| 3/3 |
| $219.48M |
| $4.18M |
| $70.05M |
| 65.2% |
| 4.8% |
| 72 |
| 尚无授权文本 |
| ACXP Acurx Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | — | -$1.68M | — | — | — | 56 | 尚无授权文本 |
| CCXI Churchill Capital Corp XI | 2026-03-31 | 3/3 | — | $3.17M | — | — | — | 9 | 尚无授权文本 |
| CCXIU Churchill Capital Corp XI | 2026-03-31 | 3/3 | — | $3.17M | — | — | — | 9 | 尚无授权文本 |
| CXAI CXApp Inc. | 2026-03-31 | 3/3 | $950,000 | -$4M | — | 83.2% | -434.1% | 72 | 尚无授权文本 |
| CXDO Crexendo, Inc. | 2026-03-31 | 3/3 | $20.71M | $578,000 | — | — | 2.1% | 101 | 尚无授权文本 |
| CXII Churchill Capital Corp XII | 2026-03-31 | 2/3 | — | -$44,797 | — | — | — | 5 | 尚无授权文本 |
| CXIIU Churchill Capital Corp XII | 2026-03-31 | 2/3 | — | -$44,797 | — | — | — | 5 | 尚无授权文本 |
| CXT Crane NXT, Co. | 2026-03-31 | 3/3 | $387.7M | $6.4M | — | 40.2% | 5.7% | 81 | 尚无授权文本 |
| CXW CoreCivic, Inc. | 2026-03-31 | 3/3 | $614.73M | $37.92M | — | — | — | 95 | 尚无授权文本 |
| DTCX Datacentrex, Inc. | 2026-03-31 | 3/3 | $2.18M | -$6.15M | — | 23.5% | -230.3% | 62 | 尚无授权文本 |
| FCX FREEPORT-MCMORAN INC | 2026-03-31 | 3/3 | $6.25B | $1.39B | — | 26.8% | 34.2% | 85 | 尚无授权文本 |
| IPCX Inflection Point Acquisition Corp. III | 2026-03-31 | 3/3 | $100M | $1.68M | — | — | -0.6% | 13 | 尚无授权文本 |
| IPCXU Inflection Point Acquisition Corp. III | 2026-03-31 | 3/3 | $100M | $1.68M | — | — | -0.6% | 13 | 尚无授权文本 |
| MDCX Medicus Pharma Ltd. | 2026-03-31 | 3/3 | — | -$9.04M | — | — | — | 40 | 尚无授权文本 |
| QNCX Quince Therapeutics, Inc. | 2026-03-31 | 3/3 | — | $35.91M | -$7.63M | — | — | 87 | 尚无授权文本 |
| TCX TUCOWS INC /PA/ | 2026-03-31 | 3/3 | — | -$18.11M | -$2M | — | — | 71 | 尚无授权文本 |
| TECX Tectonic Therapeutic, Inc. | 2026-03-31 | 3/3 | — | -$25.24M | -$18.43M | — | — | 95 | 尚无授权文本 |
| LRCX LAM RESEARCH CORP | 2026-03-29 | 3/3 | $5.84B | $1.83B | — | 49.8% | 35.0% | 76 | 尚无授权文本 |
| ATCX ATLAS CRITICAL MINERALS Corp | 2025-12-31 | 3/3 | $92,491 | -$5.42M | -$3.79M | -64.3% | -5787.6% | 19 | 尚无授权文本 |
| DCX Digital Currency X Technology Inc. | 2025-12-31 | 3/3 | — | -$30.07M | — | — | — | 67 | 尚无授权文本 |
| ECX ECARX Holdings Inc. | 2025-12-31 | 3/3 | $847.86M | -$66.04M | -$106.56M | 19.0% | -6.5% | 71 | 尚无授权文本 |
| CX CEMEX SAB DE CV | 2024-12-31 | 2/3 | — | $960M | — | — | — | 311 | 尚无授权文本 |
| BCX BlackRock Resources & Commodities Strategy Trust | — | 0/3 | — | — | — | — | — | 1 | 尚无授权文本 |
| SPCX SPACE EXPLORATION TECHNOLOGIES CORP | — | 0/3 | — | — | — | — | — | 6 | 尚无授权文本 |
| VCX Fundrise Innovation Fund, LLC | — | 0/3 | — | — | — | — | — | 1 | 尚无授权文本 |